![criteria for semaglutide PDF] 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Data collection timeline. The observation](https://figures.semanticscholar.org/898978c1b0543b943d605e293f5296fb7568cee7/3-Figure1-1.png)
criteria for semaglutide PDF] 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Data collection timeline. The observation
USD23.39
USD51.39
Pay in 4 interest-free payments of $5.85 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
![criteria for semaglutide PDF] 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Data collection timeline. The observation](https://www.researchgate.net/publication/373198539/figure/fig1/AS:11431281454663859@1747962456638/Data-collection-timeline-The-observation-period-for-inclusion-and-exclusion-criteria-of_Q320.jpg)
![criteria for semaglutide PDF] 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Data collection timeline. The observation](https://cdn.prod.website-files.com/6a0ccac3db38d1a0339ab054/6a0ccac3db38d1a0339aba8c_662f1824865c524dfc27c481_Eden%2520Blog%2520Banners%2520%2520(4).webp)
![criteria for semaglutide PDF] 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Data collection timeline. The observation](https://i.ytimg.com/vi/Fp8OsqmU9vk/hq720.jpg?sqp=-oaymwE7CK4FEIIDSFryq4qpAy0IARUAAAAAGAElAADIQj0AgKJD8AEB-AH-CYAC0AWKAgwIABABGGUgZShlMA8=&rs=AOn4CLDmZB4QQoYw0PdcVyn1Yw7xb3-nhA)
![criteria for semaglutide PDF] 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial Data collection timeline. The observation](https://www.mdpi.com/jcm/jcm-13-05166/article_deploy/html/images/jcm-13-05166-g001-550.jpg)
